12 days ago
MIRM
AnalystsMichael UlzMichael Ulz's Stock Forecasts
AnalystsMichael Ulz
Sectors:
Industries:
Analyst Ranking
Top 8%
#385 out of 5301 analysts
Average Return
+22.29%
Win Rate
58%55 out of 95
Risk vs Reward
Poor
Good
Michael Ulz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kyverna Therapeutics IncKYTX | +335.86% | $1.98 | $8.63 | 2025-04-01 - 2026-03-31 | Strong Buy |
Silence Therapeutics PLCSLN | +310.96% | $5.29 | $21.74 | 2023-07-24 - 2024-07-23 | Strong Buy |
Alpine Immune Sciences IncALPN | +300.75% | $16.07 | $64.40 | 2023-11-03 - 2024-04-11 | Strong Buy |
Silence Therapeutics PLCSLN | +261.98% | $5.76 | $20.85 | 2023-06-12 - 2024-06-11 | Strong Buy |
Iveric Bio IncISEE | +255.14% | $11.19 | $39.74 | 2022-07-07 - 2023-07-06 | Strong Buy |
Michael Ulz Analyst Color
Get additional color on Michael Ulz's coverage of popular stocks
2 months ago
MIRM
2 months ago
IONS
2 months ago
ARWR
6 months ago
DYN
6 months ago
MIRM
7 months ago
KYTX
8 months ago
IONS
8 months ago
VKTX
8 months ago
MIRM
8 months ago
IONS
9 months ago
IONS
a year ago
AKRO
2 years ago
DYN
2 years ago
THRD
2 years ago
SLN
2 years ago
MIRM
2 years ago
ALPN
Michael Ulz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mirum Pharmaceuticals IncMIRM | 8 | Strong Buy | $150.00 | +40.02% | Maintains | 12 days ago |
Aardvark Therapeutics IncAARD | 3 | Strong Sell | $3.00 | -23.66% | Downgrades | a month ago |
Ionis Pharmaceuticals IncIONS | 9 | Strong Buy | $130.00 | +75.39% | Maintains | 2 months ago |
Arrowhead Pharmaceuticals IncARWR | 8 | Strong Buy | $100.00 | +22.22% | Upgrades | 2 months ago |
Karyopharm Therapeutics IncKPTI | 9 | Buy | $15.00 | +66.30% | Maintains | 3 months ago |
Cabaletta Bio IncCABA | 7 | Strong Buy | $13.00 | +357.75% | Maintains | 3 months ago |
Dyne Therapeutics IncDYN | 4 | Strong Buy | $47.00 | +137.37% | Maintains | 4 months ago |
Fractyl Health IncGUTS | 3 | Hold | $2.00 | +133.10% | Downgrades | 5 months ago |
Alnylam Pharmaceuticals IncALNY | 13 | Hold | $408.00 | +46.72% | Maintains | 5 months ago |
Kyverna Therapeutics IncKYTX | 3 | Strong Buy | $25.00 | +209.79% | Maintains | 7 months ago |
Viking Therapeutics IncVKTX | 4 | Strong Buy | $102.00 | +235.75% | Maintains | 8 months ago |
Silence Therapeutics PLCSLN | 12 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Y Mabs Therapeutics IncYMAB | 6 | Strong Sell | $7.00 | N/A | Maintains | a year ago |
Iovance Biotherapeutics IncIOVA | 4 | Buy | $20.00 | N/A | Maintains | a year ago |
Third Harmonic Bio IncTHRD | 5 | Hold | $5.00 | N/A | Downgrades | a year ago |
Akero Therapeutics IncAKRO | 4 | Strong Buy | $96.00 | N/A | Maintains | a year ago |
Blueprint Medicines CorpBPMC | 9 | Hold | $115.00 | N/A | Maintains | 2 years ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | N/A | Downgrades | 2 years ago |
Fate Therapeutics IncFATE | 7 | Hold | $7.00 | N/A | Maintains | 2 years ago |
Kalaris Therapeutics IncKLRS | 4 | Strong Sell | $11.50 | N/A | Downgrades | 2 years ago |
Oric Pharmaceuticals IncORIC | 2 | Buy | $27.00 | N/A | Maintains | 3 years ago |
Mirati Therapeutics IncMRTX | 8 | Hold | $37.00 | N/A | Maintains | 3 years ago |
Iveric Bio IncISEE | 3 | Strong Buy | $35.00 | N/A | Maintains | 3 years ago |
Senti Biosciences Holdings IncSNTI | 3 | Hold | $20.00 | N/A | Maintains | 3 years ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Xilio Therapeutics IncXLO | 3 | Strong Buy | $140.00 | N/A | Maintains | 3 years ago |
Allakos IncALLK | 4 | Hold | $8.00 | N/A | Maintains | 3 years ago |
Taysha Gene Therapies IncTSHA | 1 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Vir Biotechnology IncVIR | 1 | Hold | $30.00 | N/A | Upgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Strong Buy | $90.00 | N/A | Maintains | 4 years ago |
Jounce Therapeutics IncJNCE | 3 | Hold | $7.00 | N/A | Downgrades | 4 years ago |
Tectonic Therapeutic IncTECX | 2 | Hold | $36.00 | N/A | Maintains | 4 years ago |
Igm Biosciences IncIGMS | 2 | Hold | $38.00 | N/A | Downgrades | 5 years ago |
Iteos Therapeutics IncITOS | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 6 years ago |
Neurogene IncNGNE | 1 | Buy | $125.00 | N/A | Initiates Coverage On | 6 years ago |
Mersana Therapeutics IncMRSN | 2 | Buy | $500.00 | N/A | Maintains | 6 years ago |
Atreca IncBCEL | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Merrimack Pharmaceuticals IncMACK | 2 | Hold | $4.00 | N/A | Maintains | 8 years ago |
Aceragen IncACGN | 1 | Buy | $4.00 | N/A | Maintains | 8 years ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Buy | $80.00 | N/A | Maintains | 9 years ago |
Amicus Therapeutics IncFOLD | 2 | Buy | $15.00 | N/A | Maintains | 9 years ago |
Tesaro IncTSRO | 1 | Hold | $182.00 | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.